ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Summary
journal-article
Research Fellow at Newcastle University Centre for Cancer. Interests: stem cell models, prostate cancer biology, organogenesis and genome editing. š¬
Prostate Cancer UK Fellow
United Kingdom of Great Britain and Northern Ireland
ā
Summary
journal-article
Published by
Communications Biology
Summary
journal-article
Published by
Oncogene
Summary
journal-article
Published by
Development
Summary
journal-article
Published by
The Journal of Pathology
Summary
journal-article
Published by
Clinical and Translational Medicine
Summary
journal-article
Published by
International Journal of Molecular Sciences
Summary
journal-article
Published by
Stem cell research
Summary
journal-article
Published by
International Journal of Molecular Sciences
Summary
journal-article
Published by
International Journal of Molecular Sciences
Summary
journal-article
Published by
Stem Cells Translational Medicine
Summary
journal-article
Published by
Molecular Therapy - Methods & Clinical Development
Summary
journal-article
Published by
Nature Communications
Summary
journal-article
Published by
Scientific Reports
Summary
journal-article
Published by
STEM CELLS
Summary
journal-article
Published by
Cell Death & Disease
Summary
journal-article
Published by
Forensic Science International: Genetics
Summary
journal-article
Published by
Journal of Forensic Sciences
Summary
journal-article